You are here:HomeLive TVVideosExpect $125-150 Mn From Oral Contraceptives Business: Lupin

Expect $125-150 mn from oral contraceptives business: Lupin

loading..

Lupin has received approval to launch the generic version of oral contraceptive Yasmin in the US. Ramesh Swaminathan, president of finance and planning, Lupin, explains this is a crucial product for the pharma company and could help them garner $125-150 million dollars over time. He adds that Lupin has a strong pipeline of launches for the year ahead as well.

MORE FROM NDTV

FROM THE WEB

MORE FROM THE WEB
MORE FROM NDTV

Social Sharing

Advertisement

Advertisement

 

More From NDTV

More From the WEB

Advertisement

Market Data provided by © Accord Fintech.
© Copyright NDTV Convergence Limited 2014. All rights reserved.